Methamphetamine use behaviors and gender differences

被引:322
|
作者
Brecht, ML
O'Brien, A
von Mayrhauser, C
Anglin, MD
机构
[1] Univ Calif Los Angeles, Integrated Subst Abuse Programs, Los Angeles, CA 90025 USA
[2] Calif State Univ Northridge, Dept Anthropol, Northridge, CA 91330 USA
关键词
methamphetamine; gender differences; drug use behaviors;
D O I
10.1016/S0306-4603(03)00082-0
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This analysis describes methamphetamine (MA) use behaviors in a broad cross-section of (N = 350) former clients from a large publicly funded treatment system and examines differences between males and females in drug use history, MA initiation and motivators, MA-related problems, acquisition, distribution, manufacture, and treatment characteristics. Results show polydrug use, prolonged MA use before treatment, initiation primarily through friends, common sensation-seeking motivators (to have fun, get high, and experiment), numerous problems related to MA use (including paranoia, violent behavior, hallucinations, financial problems, and legal and work problems), and a majority who have sold MA. Gender differences appear in selected aspects of motivators and routes of initiation, access to MA, use patterns, and MA-related problems. Such description of behaviors and gender differences can provide a basis for development of treatment strategies and points of departure for future research. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:89 / 106
页数:18
相关论文
共 50 条
  • [1] Gender Differences in Methamphetamine Use Initiation and Trajectory of Use Among People Who Use Methamphetamine in a Mexico-US Border City
    Loza, Oralia
    Guevara, Priscilla
    Hernandez, Amir
    ADDICTIVE DISORDERS & THEIR TREATMENT, 2021, 20 (04) : 288 - 302
  • [2] Gender Differences in the Use of Parental Alienating Behaviors
    Harman, Jennifer J.
    Lorandos, Demosthenes
    Biringen, Zeynep
    Grubb, Caitlyn
    JOURNAL OF FAMILY VIOLENCE, 2020, 35 (05) : 459 - 469
  • [3] Gender Differences in the Use of Parental Alienating Behaviors
    Jennifer J. Harman
    Demosthenes Lorandos
    Zeynep Biringen
    Caitlyn Grubb
    Journal of Family Violence, 2020, 35 : 459 - 469
  • [4] Association of methamphetamine use with depressive symptoms and gender differences in this association: a meta-analysis
    He, Yiqin
    Zhai, Jin
    Liu, Yangyang
    JOURNAL OF SUBSTANCE USE, 2020, 25 (04) : 440 - 448
  • [5] Gender differences in the behavioral effects of methamphetamine
    Schindler, CW
    Bross, JG
    Thorndike, EB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 442 (03) : 231 - 235
  • [6] A qualitative exploration of perceived gender differences in methamphetamine use among women who use methamphetamine on the Mexico-US border
    Loza, Oralia
    Ramos, Rebeca
    Ferreira-Pinto, Joao
    Hernandez, Maria Teresa
    Villalobos, Susana A.
    JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE, 2016, 15 (04) : 405 - 424
  • [7] Gender differences in the behavioral and subjective effects of methamphetamine in healthy humans
    Mayo, Leah M.
    Paul, Elisabeth
    DeArcangelis, Jessica
    Van Hedger, Kathryne
    de Wit, Harriet
    PSYCHOPHARMACOLOGY, 2019, 236 (08) : 2413 - 2423
  • [8] Gender differences in the behavioral and subjective effects of methamphetamine in healthy humans
    Leah M. Mayo
    Elisabeth Paul
    Jessica DeArcangelis
    Kathryne Van Hedger
    Harriet de Wit
    Psychopharmacology, 2019, 236 : 2413 - 2423
  • [9] Methamphetamine use by high school students: Recent trends, gender and ethnicity differences, and use of other drugs
    Oetting, ER
    Deffenbacher, JL
    Taylor, MJ
    Luther, N
    Beauvais, F
    Edwards, RW
    JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE, 2000, 10 (01) : 33 - 50
  • [10] Contextualizing gender differences and methamphetamine use with HIV prevalence within a South African community
    Wechsberg, Wendee M.
    Doherty, Irene A.
    Myers, Bronwyn
    Morgan-Lopez, Antonio A.
    Emanuel, Andrea
    Carney, Tara
    Kline, Tracy L.
    Zule, William A.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (03) : 583 - 590